Patent · US Active

Methods for the treatment of IL-1β related conditions

US8551487B2 · kind B2 · utility

1Cited by
30References
83Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2011
Grant dateOct 8, 2013
Priority date—
Expiry dateMay 6, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1β binding molecules (e.g., IL-1β binding antibodies or binding fragment thereof).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.